Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Operationalizing diffusion magnetic resonance imaging positivity for detection of vascular contributions to impairment and dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Regional diffusion imaging measures to disentangle SVD-related hypertensive arteriopathy versus cerebral amyloid angiopathy.

Molecular neurodegeneration·2026
Same author

Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.

Brain : a journal of neurology·2026
Same author

Circumferential actomyosin bundles anchored by CCM1 drive endothelial cell contraction and vessel constriction.

Nature communications·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Mingzhao Hu1

  • 1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

脑血管疾病 (CeVD) 生物标志物,包括扩散MRI测量,比白质超强度 (WMH) 早10年表现出进展. 这一发现有助于早期检测和干预血管对认知障碍 (VCI) 的贡献.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经成像是一种神经成像.
  • 神经学 神经学
  • 生物标志物发现发现

背景情况:

  • 脑血管疾病 (CeVD) 是阿尔茨海默氏症的关键共同病理,影响认知障碍 (VCI) 估计.
  • 目前CeVD的操作性有限,这阻碍了对血管对认知障碍的贡献的准确评估.
  • 新的扩散MRI标记物 (FA,FW,PSMD,ARTS) 和WMH被提出作为CeVD早期和晚期变化的替代物.

研究的目的:

  • 描述CeVD生物标志物的时间进展,包括扩散MRI标志物和WMH.
  • 建立可靠的切割点来分类正常与异常CeVD生物标志物状态.
  • 加强CeVD生物标志物分期,以提高临床效用.

主要方法:

  • 利用3,953名梅奥诊所老龄化参与者研究中的CeVD生物标志物数据进行分类和切割点估计.
  • 采用非线性混合效应 (NLME) 模型来分析来自2047名参与者的纵向数据,检查时间进展.
  • 将年龄,性别,血管风险,教育和APOE4状态等共变量纳入时间进展模型.

主要成果:

  • 扩散MRI生物标志物始终在比白质超强度 (WMH) 早大约10年表现出进展.
  • 全脑扩散MRI测量 (FW,PSMD,ARTS) 与WMH有很高的相关性,表明与时间偏移的同步进展.
  • 区域真实指标在几十年内表现出更早,更稳定的进展,与WMH的相关性较低.

结论:

  • 使用VCI分类的扩散MRI标记器的确定的切点,准确度年轻的参考标准显示出卓越的性能.
  • 与WMH相比,扩散MRI标记表明CeVD进展较早,这强调了它们的早期检测潜力.
  • 这些发现支持扩散MRI标记物的使用,以改善CeVD和VCI的临床评估和有针对性的干预措施.